The Conflicts of Interest statement should be corrected to include a list of potential conflicts. Dr Hamblin is on the following Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St Paul MN; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX. Dr Hamblin has been a consultant for USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V.; Johnson & Johnson Inc, Philadelphia, PA; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Photothera Inc, Carlsbad, CA. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
CITATION STYLE
Heiskanen, V., & Hamblin, M. R. (2019). Correction: Photobiomodulation: lasers vs. light emitting diodes? (Photochemical & Photobiological Sciences (2018) 17 (1003–1017) DOI: 10.1039/C8PP00176F). Photochemical and Photobiological Sciences. Royal Society of Chemistry. https://doi.org/10.1039/C8PP90049C
Mendeley helps you to discover research relevant for your work.